HealthPhoto: Aaj TakFDA Updates Safety Label for Weight Loss Drugs Over Eye Stroke Risk
The US FDA has updated safety labeling for diabetes and obesity drugs like semaglutide and tirzepatide. Research indicates long-term use of these GLP-1 drugs increases the risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (eye stroke). This change aims to inform patients and healthcare providers about potential eye risks.
Aaj Tak·


